Abstract
During the research the comparative analysis of protocols of medical care for patients with brain injuries and information of scientific literature and evidence-based medicine has been conducted. It has demonstrated that for the treatment of affected military men with brain injury the following groups of drugs are used: antibacterial agents for systemic use, psychoanaleptics, blood substitutes and perfusion solutions, antiepileptics, vitamins, peripheral vasodilators, cardiac drugs, calcium channel blockers, analgesics, antihemorrhagic drugs, drugs for treating wounds and ulcers, diuretics, antithrombotic agents, antiparkinsonian drugs, psycholeptics, vasoprotectives, beta adrenoreceptor antagonists, etc. Marketing analysis of certain groups of drugs has been conducted according to the following criteria: legal (registration in Ukraine), economic (commercial: country, company), pharmaceutical (types of dosage forms, the composition of active substances, method of application), pharmacotherapeutic (ATC-classification). The analysis of the domestic pharmaceutical market has shown that drugs for treatment of head injuries comprise 1034 drugs manufactured in 39 countries. It has been found that the Ukrainian producers are able to provide the necessary level of rendering medical care in treatment of the traumatic brain injury, they produce 549 names of drugs, and it is almost 53% of the total range of medicines. The first place among the Ukrainian companies manufacturing drugs for treatment of the brain injury has “Darnitsa pharmaceutical company” JSC, the second one – “Yuriа-Farm” Ltd., the third place – Pharmaceutical company “Zdorovye” Ltd. Foreign producers supply 485 drugs (47%). The leaders are India, Germany and Slovenia, which take the first, second and third places in the import of drugs, respectively.
Highlights
Modern principles of qualitative medical care are associated with unification and standardization of the medical technologies, and it fully regards to drug provision of affected military men with with brain injuries
In order to standardize the provision of medical care, implementation of modern methods of diagnosis and treatment of brain injuries into the activities of medical preventive institutions, as well as the quality control of medical care, in 1998 the standards of medical care for victims of brain injury were developed, in 2004 the guidance “Modern principles of diagnosis and treatment of patients with urgent neurosurgical disorders” was writen, and in 2006 twelve protocols of rendering medical care in the specialty “Neurosurgery” were approved, in them the main directions of drug therapy of patients and pharmacological groups of drugs were determined [1, 3, 4]
The rational selection of drugs to these lists can be made using the methods of pharmacoeconomic analysis; the first step is determining the basic pharmacological groups of drugs used to treat brain injuries, followed
Summary
During analysis the research materials were data of protocols of medical care for patients with brain injuries, information of scientific literature and evidencebased medicine [1]. For analysis of groups of drugs the system-overview and marketing methods have been used. When conducting marketing analysis the following groups of parameters were used: 1) legal (registration in Ukraine), 2) economic (commercial: country, company), 3) pharmaceutical (types of dosage forms, the composition of active substances, method of application), 4) pharmacotherapeutic (ATC-classification, the mechanism of action) [5]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
